- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Pharmaceutical company funding and its consequences: A qualitative systematic review
Abstract
This article systematically reviews published studies of the association of pharmaceutical industry funding and clinical trial results, as well a few closely related studies. It reviews two earlier results, and surveys the recent literature. Results are clear: Pharmaceutical company sponsorship is strongly associated with results that favor the sponsors' interests.Author's Profile
Other Versions
No versions found
Links
PhilArchive
External links
(no proxy)
Setup an account with your affiliations in order to access resources via your University's proxy server
Through your library
- Only published works are available at libraries.
My notes
Similar books and articles
Evaluating solutions to sponsorship bias.M. Doucet & S. Sismondo - 2008 - Journal of Medical Ethics 34 (8):627-630.
Is there a funding bias in biomedical research?Francesc Roig-Loscertales - 2026 - Theoria: Revista de Teoría, Historia y Fundamentos de la Ciencia 41 (1):87-102.
Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company.Ray Moynihan - 2020 - Journal of Bioethical Inquiry 17 (1):61-63.
Conflicts of interest in drug development: The practices of merck & co., inc.Laurence J. Hirsch - 2002 - Science and Engineering Ethics 8 (3):429-442.
IRBs and Pharmaceutical Company Funding of Research.Michael S. Jellinek - 1982 - IRB: Ethics & Human Research 4 (8):9.
Biomedical Research and Corporate Interests: A Question of Academic Freedom.L. McHenry - 2008 - Mens Sana Monographs 6 (1):146.
Conflicting interests: The evolution of an issue.David Healy - 2004 - Monash Bioethics Review 23 (4):8-18.
The effects of industry funding and positive outcomes in the interpretation of clinical trial results: a randomized trial among Dutch psychiatrists.Joeri K. Tijdink, Yvo M. Smulders, Lex M. Bouter & Christiaan H. Vinkers - 2019 - BMC Medical Ethics 20 (1):1-8.
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications. [REVIEW]Joel Lexchin - 2012 - Science and Engineering Ethics 18 (2):247-261.
Institutional mistrust in the organization of pharmaceutical clinical trials.Jill A. Fisher - 2008 - Medicine, Health Care and Philosophy 11 (4):403-413.
Analytics
Added to PP
2009-01-28
Downloads
136 (#324,693)
6 months
70 (#140,609)
2009-01-28
Downloads
136 (#324,693)
6 months
70 (#140,609)
Historical graph of downloads
Author's Profile
Citations of this work
It Takes a Village to Trust Science: Towards a (Thoroughly) Social Approach to Public Trust in Science.Gabriele Contessa - 2023 - Erkenntnis 88 (7):2941-2966.
Science, Values, and the New Demarcation Problem.David B. Resnik & Kevin C. Elliott - 2023 - Journal for General Philosophy of Science / Zeitschrift für Allgemeine Wissenschaftstheorie 54 (2):259-286.
The promise and perils of industry‐funded science.Bennett Holman & Kevin C. Elliott - 2018 - Philosophy Compass 13 (11):e12544.
Disclosing and managing non-financial conflicts of interest in scientific publications.David Resnik - 2023 - Research Ethics 19 (2):121-138.
Feyerabend and manufactured disagreement: reflections on expertise, consensus, and science policy.Jamie Shaw - 2020 - Synthese 198 (Suppl 25):6053-6084.
Try MATCHA Writer if you're interested in citing directly from PhilPapers and certifying your authorship.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation